loadpatents
Patent applications and USPTO patent grants for Hennequin; Laurent Francois Andre.The latest application filed is for "quinazoline derivatives as vegf inhibitors".
Patent | Date |
---|---|
Quinazoline Derivatives as VEGF Inhibitors App 20210276972 - Thomas; Andrew Peter ;   et al. | 2021-09-09 |
Quinazoline Derivatives as VEGF Inhibitors App 20200262811 - Thomas; Andrew Peter ;   et al. | 2020-08-20 |
Quinazoline derivatives as VEGF inhibitors Grant 10,457,664 - Thomas , et al. Oc | 2019-10-29 |
Quinazoline Derivatives as VEGF Inhibitors App 20190002433 - Thomas; Andrew Peter ;   et al. | 2019-01-03 |
Quinazoline Derivatives as VEGF Inhibitors App 20180099946 - Thomas; Andrew Peter ;   et al. | 2018-04-12 |
Quinazoline Derivatives as VEGF Inhibitors App 20160130249 - Thomas; Andrew Peter ;   et al. | 2016-05-12 |
Quinazoline derivatives as VEGF inhibitors Grant 9,040,548 - Thomas , et al. May 26, 2 | 2015-05-26 |
Quinazoline derivatives as tyrosine kinase inhibitors Grant 8,735,410 - Halsall , et al. May 27, 2 | 2014-05-27 |
Quinazoline Derivatives as VEGF Inhibitors App 20140121228 - Thomas; Andrew Peter ;   et al. | 2014-05-01 |
Quinazoline derivatives as VEGF inhibitors Grant 8,642,608 - Thomas , et al. February 4, 2 | 2014-02-04 |
4-anilino quinazoline derivatives as antiproliferative agents Grant 8,399,667 - Bradbury , et al. March 19, 2 | 2013-03-19 |
Quinazoline Derivatives App 20130005727 - BRADBURY; Robert Hugh ;   et al. | 2013-01-03 |
Quinazoline Derivatives App 20120329795 - Hennequin; Laurent Francois Andre ;   et al. | 2012-12-27 |
Quinazoline compounds Grant 8,293,902 - Hennequin October 23, 2 | 2012-10-23 |
Quinazoline Derivatives as Angiogenesis Inhibitors App 20120046300 - Hennequin; Laurent Francois Andre | 2012-02-23 |
Quinazoline Derivatives as Antiproliferative Agents App 20110237610 - Barlaam; Bernard Christophe ;   et al. | 2011-09-29 |
Quinazoline derivatives as angiogenesis inhibitors Grant 7,989,460 - Hennequin August 2, 2 | 2011-08-02 |
Quinazoline Derivatives As Tyrosine Kinase Inhibitors App 20110152297 - Halsall; Christopher Thomas ;   et al. | 2011-06-23 |
Quinazoline derivatives and pharmaceutical compositions containing them Grant RE42,353 - Thomas , et al. May 10, 2 | 2011-05-10 |
Quinazoline Derivatives And Pharmaceutical Compositions Containing Them App 20110071144 - THOMAS; Andrew Peter ;   et al. | 2011-03-24 |
Quinazoline Derivatives As Vegf Inhibitors App 20110065736 - Thomas; Andrew Peter ;   et al. | 2011-03-17 |
Quinazoline derivatives as antiproliferative agents Grant 7,838,530 - Barlaam , et al. November 23, 2 | 2010-11-23 |
Quinazoline Derivatives For The Treatment Of Tumours App 20100280042 - HENNEQUIN; Laurent Francois Andre ;   et al. | 2010-11-04 |
4-anilino Quinazoline Derivatives As Antiproliferative Agents App 20100152442 - Bradbury; Robert Hugh ;   et al. | 2010-06-17 |
Quinazoline derivatives for the treatment of tumours Grant 7,696,214 - Hennequin , et al. April 13, 2 | 2010-04-13 |
Quinazoline derivatives and their use in the treatment of cancer Grant 7,659,279 - Hennequin , et al. February 9, 2 | 2010-02-09 |
Quinazoline Derivatives As Tyrosine Kinase Inhibitors App 20090312343 - HENNEQUIN; Laurent Francois Andre ;   et al. | 2009-12-17 |
Quinazoline compounds for the treatment of hyperproliferative disorders Grant 7,632,840 - Delouvrie , et al. December 15, 2 | 2009-12-15 |
Quinazoline derivatives Grant 7,625,908 - Hennequin , et al. December 1, 2 | 2009-12-01 |
Quinazoline derivatives as tyrosine kinase inhibitors Grant 7,569,577 - Hennequin , et al. August 4, 2 | 2009-08-04 |
Quinzoline derivatives for use in the treatment of cancer Grant 7,504,408 - Hennequin , et al. March 17, 2 | 2009-03-17 |
Quinoline derivatives and their use as tyrosine kinase inhibitors Grant 7,501,516 - Hennequin March 10, 2 | 2009-03-10 |
Method of producing an antiangiogenic or vascular permeability reducing effect Grant 7,498,335 - Hennequin , et al. March 3, 2 | 2009-03-03 |
Quinoline Derivatives Having Vegf Inhibiting Activity App 20080312273 - Hennequin; Laurent Francois Andre | 2008-12-18 |
4-anilino Quinazoline Derivatives As Antiproliferative Agents App 20080269487 - Bradbury; Robert Hugh ;   et al. | 2008-10-30 |
Quinazoline Derivatives App 20080234263 - Hennequin; Laurent Francois Andre ;   et al. | 2008-09-25 |
Quinoline derivatives having VEGF inhibiting activity Grant 7,371,765 - Hennequin May 13, 2 | 2008-05-13 |
Quinazoline Derivatives App 20080096881 - Hennequin; Laurent Francois Andre ;   et al. | 2008-04-24 |
Quinazoline Derivatives As Angiogenesis Inhibitors App 20080058342 - Hennequin; Laurent Francois Andre | 2008-03-06 |
Quinazoline compounds App 20080027069 - Hennequin; Laurent Francois Andre | 2008-01-31 |
Quinazoline Derivatives App 20070293490 - Delouvrie; Benedicte ;   et al. | 2007-12-20 |
Quinazoline derivatives as VEGF inhibitors App 20070265286 - Thomas; Andrew Peter ;   et al. | 2007-11-15 |
Quinazoline Derivatives App 20070244136 - Hennequin; Laurent Francois Andre ;   et al. | 2007-10-18 |
Substituted 3-cyanoquinolines as MEK inhibitors App 20070213367 - Hennequin; Laurent Francois Andre ;   et al. | 2007-09-13 |
Quinazoline compounds Grant 7,268,230 - Hennequin September 11, 2 | 2007-09-11 |
3-Cyano-quinoline derivatives App 20070191346 - Hennequin; Laurent Francois Andre | 2007-08-16 |
Quinazoline derivatives App 20070099943 - Bradbury; Robert Hugh ;   et al. | 2007-05-03 |
Quinazoline derivatives as antitumor agents App 20070088044 - Hennequin; Laurent Francois Andre ;   et al. | 2007-04-19 |
Quinazoline derivatives as antitumor agents App 20070082921 - Hennequin; Laurent Francois Andre ;   et al. | 2007-04-12 |
Quinazoline compounds App 20070066633 - Hennequin; Laurent Francois Andre ;   et al. | 2007-03-22 |
Quinazoline derivatives App 20070043010 - Bradbury; Robert Hugh ;   et al. | 2007-02-22 |
Quinazoline derivatives as tyrosine kinase inhibitors App 20070043009 - Hennequin; Laurent Francois Andre ;   et al. | 2007-02-22 |
Quinazoline derivatives App 20070037837 - Hennequin; Laurent Francois Andre ;   et al. | 2007-02-15 |
Quinazoline derivatives App 20070032513 - Hennequin; Laurent Francois Andre ;   et al. | 2007-02-08 |
Quinazoline derivatives as tyrosine kinase inhibitors App 20070032508 - Bradbury; Robert Hugh ;   et al. | 2007-02-08 |
Substituted 3-cyanoquinolines as MEK inhibitors Grant 7,173,135 - Hennequin , et al. February 6, 2 | 2007-02-06 |
3-Cyano-quinoline derivatives Grant 7,173,136 - Hennequin February 6, 2 | 2007-02-06 |
Quinazoline derivatives as VEGF inhibitors Grant 7,173,038 - Thomas , et al. February 6, 2 | 2007-02-06 |
Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases App 20070027145 - Hennequin; Laurent Francois Andre | 2007-02-01 |
Quinazoline derivatives as antitumor agents App 20070015743 - Bradbury; Robert Hugh ;   et al. | 2007-01-18 |
Quinazoline compounds Grant 7,160,889 - Hennequin , et al. January 9, 2 | 2007-01-09 |
Quinazoline derivatives as antiproliferative agents App 20060287295 - Barlaam; Bernard Christophe ;   et al. | 2006-12-21 |
Quinazoline derivatives Grant 7,148,230 - Bradbury , et al. December 12, 2 | 2006-12-12 |
Quinazoline derivatives for the treatment of tumours App 20060258642 - Hennequin; Laurent Francois Andre ;   et al. | 2006-11-16 |
Quinazoline derivatives Grant 7,115,615 - Hennequin , et al. October 3, 2 | 2006-10-03 |
Quinazoline derivatives and their use in the treatment of cancer App 20060211714 - Hennequin; Laurent Francois Andre ;   et al. | 2006-09-21 |
Cinnoline derivatives and use as medicine Grant 7,087,602 - Thomas , et al. August 8, 2 | 2006-08-08 |
Chemical compounds App 20060148819 - Hennequin; Laurent Francois Andre | 2006-07-06 |
Quinazoline derivatives for treatment of tumours Grant 7,049,438 - Hennequin , et al. May 23, 2 | 2006-05-23 |
Substituted 3-cyanoquinolines as mek inhibitors App 20060089382 - Hennequin; Laurent Francois Andre ;   et al. | 2006-04-27 |
3-Cyano-quinoline derivatives App 20050282856 - Hennequin, Laurent Francois Andre | 2005-12-22 |
Quinzoline derivatives for use in the treatment of cancer App 20050250797 - Hennequin, Laurent Francois Andre ;   et al. | 2005-11-10 |
4-anilino quinazoline derivatives as antiproliferative agents App 20050215574 - Bradbury, Robert Hugh ;   et al. | 2005-09-29 |
Quinazoline derivatives App 20050165035 - Bradbury, Robert Hugh ;   et al. | 2005-07-28 |
Quinazoline derivatives and pharmaceutical compositions containing them Grant 6,897,210 - Thomas , et al. May 24, 2 | 2005-05-24 |
Cinnoline compounds Grant 6,887,874 - Hennequin May 3, 2 | 2005-05-03 |
Quinazoline compounds App 20050085465 - Hennequin, Laurent Francois Andre | 2005-04-21 |
Quinazoline derivatives as antitumor agents App 20050054662 - Hennequin, Laurent Francois Andre ;   et al. | 2005-03-10 |
Quinoline derivatives and their use as tyrosine kinase inhibitors App 20050009867 - Hennequin, Laurent Francois Andre | 2005-01-13 |
Quinazoline Derivatives And Pharmaceutical Compositions Containing Them App 20040242574 - Thomas, Andrew Peter ;   et al. | 2004-12-02 |
Quinazoline derivatives for treatment of tumours App 20040214841 - Hennequin, Laurent Francois Andre ;   et al. | 2004-10-28 |
Quinoline derivatives inhibiting the effect of growth factors such as VEGF Grant 6,809,097 - Thomas , et al. October 26, 2 | 2004-10-26 |
Quinazoline derivatives App 20040034046 - Hennequin, Laurent Francois Andre ;   et al. | 2004-02-19 |
Quinazoline derivatives and pharmaceutical compositions containing them Grant 6,673,803 - Thomas , et al. January 6, 2 | 2004-01-06 |
Therapy App 20030225111 - Hennequin, Laurent Francois Andre ;   et al. | 2003-12-04 |
Cinnoline compounds App 20030212055 - Hennequin, Laurent Francois Andre | 2003-11-13 |
Quinoline derivatives having vegf inhibiting activity App 20030199491 - Hennequin, Laurent Francois Andre | 2003-10-23 |
Cinnoline derivatives and use as medicine App 20030199513 - Thomas, Andrew Peter ;   et al. | 2003-10-23 |
Quinazoline compounds App 20030191308 - Hennequin, Laurent Francois Andre ;   et al. | 2003-10-09 |
Cinnoline derivatives and use as medicine Grant 6,514,971 - Thomas , et al. February 4, 2 | 2003-02-04 |
Quinazoline derivatives and pharmaceutical compositions containing them App 20020173646 - Thomas, Andrew Peter ;   et al. | 2002-11-21 |
Quinazoline derivatives and pharmaceutical compositions containing them Grant 6,414,148 - Thomas , et al. July 2, 2 | 2002-07-02 |
Chemical compounds Grant 6,362,336 - Lohmann , et al. March 26, 2 | 2002-03-26 |
Chemical compounds App 20020032208 - Lohmann, Jean-Jacques Marcel ;   et al. | 2002-03-14 |
Oxindolylquinazoline derivatives as angiogenesis inhibitors Grant 6,294,532 - Thomas , et al. September 25, 2 | 2001-09-25 |
4-anilinoquinazoline derivatives Grant 6,291,455 - Thomas , et al. September 18, 2 | 2001-09-18 |
Oxindole derivatives Grant 6,265,411 - Thomas , et al. July 24, 2 | 2001-07-24 |
Chemical compounds Grant 6,258,951 - Lohmann , et al. July 10, 2 | 2001-07-10 |
Quinazoline derivatives as VEGF inhibitors Grant 6,184,225 - Thomas , et al. February 6, 2 | 2001-02-06 |
Chemical compounds Grant 6,071,921 - Lohmann , et al. June 6, 2 | 2000-06-06 |
Chemical compounds Grant 5,985,281 - Taylorson , et al. November 16, 1 | 1999-11-16 |
Substituted quinazolines Grant 5,962,458 - Lohmann , et al. October 5, 1 | 1999-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.